期刊文献+

维持性血液透析患者血清IL-35与心脑血管疾病的关系 被引量:1

Relationship between serum interleukin-35 in patients with maintenance hemodialysis and cardiovascular and cerebrovascular diseases
下载PDF
导出
摘要 目的探讨维持性血液透析(MHD)患者血清白细胞介素-35(IL-35)与心脑血管疾病的关系。方法选取稳定的MHD患者72例,体检健康人30例为对照组。酶联免疫吸附法测定血清IL-35。Spearman相关分析IL-35与其它指标的相关性。结果 MHD患者IL-35水平显著低于健康对照组。心脑血管疾病患者IL-35水平明显低于无心脑血管疾病者。IL-35与左室射血分数呈正相关,与高敏C反应蛋白、氨基末端脑钠肽前体、颈动脉内膜中层厚度呈负相关。结论 MHD患者血清IL-35水平与心脑血管疾病相关,血清IL-35可能成为MHD患者心脑血管疾病新的标志物。 Objective To investigate the relationship between serum level of interleukin-35 in patients with maintenance hemodialysis(MHD)and cardiovascular and cerebrovascular diseases.Methods 72 MHD patients before undergoing hemodialysis and 30 healthy controls were selected.Serum interleukin-35 was measured by enzyme-linked immunosorbant assay(ELISA).Spearman correlation was used to assess the relationship between serum interleukin-35 and other parameters.Results Serum interleukin-35 was significantly lower in MHD patients compared with control group;patients with cardiovascular and cerebrovascular diseases had lower serum interleukin-35 levels than those without cardiovascular and cerebrovascular diseases.MHD patients serum interleukin-35 showed positive correlation with left ventricular ejection fraction and negative correlation with high sensitive C reactive protein,amino-terminal pro-brain natriuretic peptide and carotid artery intima-media thickness.Conclusions Serum interleukin-35 level of MHD patients was associated with cardiovascular and cerebrovascular diseases;interleukin-35 might be a novel biomarker of cardiovascular and cerebrovascular diseases.
出处 《滨州医学院学报》 2016年第2期106-108,共3页 Journal of Binzhou Medical University
基金 滨州医学院科技计划(BY2013KJ51)
关键词 IL-35 血液透析 心血管疾病 炎症 interleukin-35 hemodialysis cardiovascular disease inflammation
  • 相关文献

参考文献8

二级参考文献49

  • 1Stenvinkel P.Inflammatory and atherosclerotic interactions in the depleted uremic patient.Blood Purif,2001,19(1):53-61.
  • 2Chawla LS,Krishnan M.Causes and consequences of inflammation on anemia management in hemodialysis patients.Hemodial Int,2009,13:222-234.
  • 3Rodriguez-Ayala E,Anderstam B,Suliman ME,et al.Enhanced RAGE-mediated NF kappa B stimulation in inflamed hemodialysis patients.Atherosclerosis,2005,180 (2):333-340.
  • 4Kutuk O,Basaga H.Inflammation meets oxidation:NF-κB as a mediator of initial lesion development in atherosclerosis.Trends Mol Med,2003,9(12):549-557.
  • 5Ghosh S,Karin M.Missing pieces in the NF-κappa B puzzle.Cell,2002,109(Suppl):S81-S96.
  • 6Menegatti E,Ronco C,Winchester JF,et al.Absence of NF-κB activation by a new polystyrene-type adsorbent designed for hemoperfusion.Blood Purif,2005,23(1):91-98.
  • 7Rangan GK,Kan G,Steer JH,et al.Altered expression of nuclear factor-kB in peripheral blood mononuclear cells in chronic haemodialysis patients.Nephrol Dial Transplant,2006,21 (4):1137-1139.
  • 8Raj DS,Boivin MA,Dominic EA,et al.Haemodialysis induces mitochondrial dysfunction and apoptosis.Eur J Clin Invest,2007,37(12):971-977.
  • 9Himmelfarb J,Stenvinkel P,Ikizler TA,et al.The elephant in uremia:Oxidant stress as a unifying concept of cardiovascular disease in uremia.Kidney Int,2002,62(5):1524-1538.
  • 10Kao MPC,Ang DS,Pall A,et al.Oxidative stress in renal dysfunction:mechanisms,clinical sequelae and therapeutic options.J Hum Hypertens,2010,24(1):1-8.

共引文献22

同被引文献4

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部